Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062822-24-000024
Filing Date
2024-05-02
Accepted
2024-05-02 16:08:32
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lxrx-20240331.htm   iXBRL 10-Q 651768
2 EX-31.1 exh311certificationofprinc.htm EX-31.1 9552
3 EX-31.2 exh312certificationofprinc.htm EX-31.2 9368
4 EX-32.1 exh321certificationofprinc.htm EX-32.1 6044
  Complete submission text file 0001062822-24-000024.txt   3990040

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20240331.xsd EX-101.SCH 21808
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lxrx-20240331_cal.xml EX-101.CAL 52676
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lxrx-20240331_def.xml EX-101.DEF 111600
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20240331_lab.xml EX-101.LAB 434112
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20240331_pre.xml EX-101.PRE 280681
55 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20240331_htm.xml XML 442879
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30111 | Film No.: 24908249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)